Search results
Herpes cure with gene editing makes progress in laboratory studies
Medical Xpress· 2 days agoPublished May 13 in Nature Communications, Jerome and his Fred Hutch team published an encouraging...
Study highlights need for cell-type-specific therapies in treatment of HIV
Medical Xpress· 2 days agoResearchers from the University of Illinois have demonstrated the importance of cell-type-specific...
Bella James
New Times San Luis Obispo· 4 hours agoNew Times has been publishing for more than 36 years in San Luis Obispo County, CA and is the largest circulated paper in the region covering local news and entertainment each week.
Efficacy and safety of novel multifunctional M10 CAR-T cells in HIV-1-infected patients: a phase I,...
Nature· 2 days agoM10 cells were also found to impose selective pressure on the latent viral reservoir. No significant treatment-related adverse effects were observed. Overall, our study supported the potential ...
CRISPR can treat common form of inherited blindness, early data hint
LiveScience· 7 hours agoThis form of vision loss, called Leber congenital amaurosis (LCA), is often evident at birth and...
Pig-Kidney Recipient Dies; Colon Cancers Surge in Teens; CRISPR Fails to Cure HIV
MedPage Today· 3 days agoRichard Slayman, the first patient ever to receive a gene-edited pig kidney, died about 2 months...
First they tried to "cure" gayness. Now they're fixated on "healing" trans people.
Mother Jones· 6 hours agoFight disinformation: Sign up for the free Mother Jones Daily newsletter and follow the news that...
Want Cosmetic Injections? Please Don’t Go to That Shady Med Spa
Glamour via Yahoo News· 1 day agoWith consequences from botulism to HIV, dozens of unsuspecting patients are paying the price of...
Q&A: Scientist partners with colleagues around the globe to make gene therapies more effective and...
Medical Xpress· 6 days agoIn a Q&A, Adair discusses the promise of gene therapies to cure an array of diseases, as well as the need for stakeholders around the world to join forces to develop the best ...
Gritstone bio Reports First Quarter 2024 Financial Results and Provides Corporate Updates
Morningstar· 6 days ago-- Favorable progression-free survival (PFS) trend observed in preliminary data from the randomized Phase 2 study evaluating GRANITE (personalized neoantigen vaccine) in front-line metastatic, microsatellite-stable colorectal cancer (MSS-CRC); mature